share_log

Invivyd | 4: Statement of changes in beneficial ownership of securities-10% Owner Adimab, LLC

Invivyd | 4：持股变动声明-股东 Adimab, LLC

SEC announcement ·  01/22 00:00
Moomoo AI 已提取核心信息
Adimab, LLC completed a sale of 5,000,000 shares of Invivyd, Inc. (IVVD) common stock on January 19, 2024. The shares were sold at a price of $3.95 per share, resulting in a total transaction value of $19,750,000. Following the transaction, Adimab, LLC's direct holdings in Invivyd amount to 21,687,906 shares. The sale was conducted in the open market.
Adimab, LLC completed a sale of 5,000,000 shares of Invivyd, Inc. (IVVD) common stock on January 19, 2024. The shares were sold at a price of $3.95 per share, resulting in a total transaction value of $19,750,000. Following the transaction, Adimab, LLC's direct holdings in Invivyd amount to 21,687,906 shares. The sale was conducted in the open market.
Adimab, LLC于2024年1月19日完成了对Invivyd, Inc.（IVVD）500万股普通股的出售。这些股票以每股3.95美元的价格出售，总交易额为19,750,000美元。交易完成后，Adimab, LLC在Invivyd的直接持股量为21,687,906股。此次出售是在公开市场上进行的。
Adimab, LLC于2024年1月19日完成了对Invivyd, Inc.（IVVD）500万股普通股的出售。这些股票以每股3.95美元的价格出售，总交易额为19,750,000美元。交易完成后，Adimab, LLC在Invivyd的直接持股量为21,687,906股。此次出售是在公开市场上进行的。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息